TG Therapeutics(TGTX) - 2025 Q4 - Earnings Call Transcript

TG Therapeutics (NasdaqCM:TGTX) Q4 2025 Earnings call February 26, 2026 08:30 AM ET Company ParticipantsAdam Waldman - Chief Commercialization OfficerCorinne Johnson - Vice President of Equity ResearchEmily Bodnar - Vice President of Equity ResearchJenna Bosco - VP of Corporate CommunicationsMichael Weiss - Chairman, President, and CEOSean Power - CFOConference Call ParticipantsBrian Cheng - Vice President and Equity Research AnalystMichael Schmidt - Managing Director and Equity Research AnalystPrakhar Agra ...